Evaluation of the type D personality and its association with cardiovascular risk and disease-related parameters in patients with systemic sclerosis
- PMID: 40787592
- PMCID: PMC12334412
- DOI: 10.1177/23971983251362595
Evaluation of the type D personality and its association with cardiovascular risk and disease-related parameters in patients with systemic sclerosis
Abstract
Objective: The objective of the study was to assess the type D personality, social inhibition, and negative affectivity and their association with cardiovascular risk and disease-related parameters in patients with systemic sclerosis.
Materials and methods: This cross-sectional study included patients with systemic sclerosis (n = 84) and controls (n = 74). We recorded the sociodemographic parameters, blood pressure (mmHg), and laboratory parameters (mg/dL) of the study groups, as well as disease-related parameters in patients with systemic sclerosis, along with the modified Rodnan skin score. The type D Scale-14 for type D personality (social inhibition and negative affectivity) and the Framingham risk score for 10-year cardiovascular disease risk to the study groups were administered.
Results: The mean age, type D Scale-14 total score, Framingham risk score, and median total modified Rodnan skin score were 55.7 ± 11.6 years, 28.2 ± 13.6, 9.1± 8.1, and 17.5 (13), respectively, in patients with systemic sclerosis. The frequency of type D personality, social inhibition, and negative affectivity was higher in patients than in controls, at 59.5% vs 14.9%, 65.5% vs 23%, and 78.6% vs 32.4%, respectively (p < 0.001 for all). The median Framingham risk score was statistically similar for patients, controls, and patients with and without type D personality (p > 0.05 for all). Compared to those without social inhibition, patients with social inhibition had higher total modified Rodnan skin scores (p = 0.011). Social inhibition exhibited a weakly positive correlation with the total modified Rodnan skin score (Spearman's ρ = 0.223), yet regression analysis did not achieve significance.
Conclusions: More than half of patients with systemic sclerosis display type D personality traits. Patients with serious skin fibrosis experience more social inhibition, so it is important to provide psychological and social support to them.
Keywords: Systemic sclerosis; cardiovascular risk score; skin fibrosis; social inhibition; type D personality.
© The Author(s) 2025.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Type D personality and social inhibition: drivers of cardiovascular risk and reduced physical activity in psoriatic arthritis.Clin Rheumatol. 2025 Mar;44(3):1163-1171. doi: 10.1007/s10067-025-07312-3. Epub 2025 Jan 30. Clin Rheumatol. 2025. PMID: 39885100 Free PMC article.
-
Stem cell transplantation for systemic sclerosis.Cochrane Database Syst Rev. 2022 Jul 29;7(7):CD011819. doi: 10.1002/14651858.CD011819.pub2. Cochrane Database Syst Rev. 2022. PMID: 35904231 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
References
-
- Denton CP, Khanna D. Systemic sclerosis. Lancet 2017; 390(10103): 1685–1699. - PubMed
-
- Sciarra I, Vasile M, Carboni A, et al. Subclinical atherosclerosis in systemic sclerosis: different risk profiles among patients according to clinical manifestations. Int J Rheum Dis 2021; 24(4): 502–509. - PubMed
-
- Psarras A, Soulaidopoulos S, Garyfallos A, et al. A critical view on cardiovascular risk in systemic sclerosis. Rheumatol Int 2017; 37(1): 85–95. - PubMed
-
- Afifi N, Khalifa MMM, Al Anany AAMMM, et al. Cardiac calcium score in systemic sclerosis. Clin Rheumatol 2022; 41(1): 105–114. - PubMed
LinkOut - more resources
Full Text Sources